Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A289VV1
Wed, 17.08.2022
HAEMATO AG
___________________________________________________________________________
HAEMATO AG publishes figures for Q2 2022: increase in revenues and EBIT compared to the previous quarter; confirmation of guidance for the full year 2022
In the second quarter of 2022, preliminary IFRS consolidated revenues increased by around 22% to EUR 66.4 million c [ … ]
Wed, 17.08.2022
HAEMATO AG
___________________________________________________________________________
HAEMATO AG publishes figures for Q2 2022: increase in revenues and EBIT compared to the previous quarter; confirmation of guidance for the full year 2022
In the second quarter of 2022, preliminary IFRS consolidated revenues increased by around 22% to EUR 66.4 million c [ … ]
Mon, 23.05.2022
HAEMATO AG
______________________________________________________________________________
HAEMATO AG publishes figures for Q1 2022: further improvement in EBIT margin and confirmation of guidance
- Group turnover decreases to EUR 54.6 million (EUR 73.9 million in Q1-2021) due to product portfolio adjustment
- Group EBITDA of EUR 2.3 million (previous year: [ … ]
Wed, 30.03.2022
HAEMATO AG
______________________________________________________________________________
HAEMATO AG publishes preliminary figures for the 2021 financial year:
Renewed increase in sales and strong rise in earnings after disproportionate growth of the new Lifestyle and Aesthetics business unit
- HAEMATO remains on course for growth: according to preliminar [ … ]
Mon, 28.03.2022
HAEMATO AG
______________________________________________________________________________
Expansion of the Executive Board of HAEMATO AG: Strengthening operational excellence
Schönefeld, 28.03.2022 - In its meeting today, the Supervisory Board of HAEMATO AG appointed Mr. Attila Strauss to the Executive Board of HAEMATO AG with effect from 01.04.2022.
Mr. A [ … ]
Tue, 15.02.2022
HAEMATO AG
DGAP-Media / 15.02.2022 / 14:45
Schönefeld, 15 February 2022 - HAEMATO PHARM GmbH ("HAEMATO"), a 100% subsidiary of HAEMATO AG (ISIN: DE000289VV1), is expanding its medical device portfolio in the fight against Corona virus. In addition to the already introduced Point-of-Care (PoC) PCR device, HAEMATO is now also marketing the Mini Dock, an [ … ]
Fri, 14.01.2022
HAEMATO AG
DGAP-Media / 14.01.2022 / 14:45
HAEMATO distributes PCR point-of-care devices for effective containment of corona pandemic
Schönefeld, 13th January 2022 - With the current omicron wave, laboratories in Germany are facing a sharp increase in PCR testing. The evaluation capacities are pushing increasingly towards their limits, especially with [ … ]
Thu, 18.11.2021
HAEMATO AG
______________________________________________________________________________
HAEMATO AG reports figures for the 3rd quarter of 2021: Further increase in revenue and earnings as well as confirmation of revenue and earnings expectations for 2021
- HAEMATO continues to grow: consolidated revenue in the third quarter of 2021 increased by 9% year-ov [ … ]
Mon, 25.10.2021
HAEMATO AG
DGAP-Media / 25.10.2021 / 10:25
HAEMATO seeks marketing authorization and plans distribution of a botulinum toxin product under its own brand in Europe
Seoul and Schönefeld, 25th October 2021 - HAEMATO PHARM GmbH ("HAEMATO"), a wholly owned subsidiary of HAEMATO AG (ISIN: DE000289VV1), is expanding its own portfolio with a botulinum toxin p [ … ]
Mon, 31.05.2021
HAEMATO AG
______________________________________________________________________________
Corporate News of HAEMATO AG:
HAEMATO AG with strong start to the year: EBIT rises in Q1 by 350 % to EUR 2.4 million and revenues by 22 % to EUR 73.9 million.
Berlin, 31.05.2021 - HAEMATO AG (ISIN: DE000289VV1), has continued its growth course in the first months of 2 [ … ]